Related Experiment Video
Updated: Oct 13, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
Kyriacos Papadopoulos1, Panayiotis Avraamides1
1Cardiology Department, Nicosia General Hospital, Nicosia, Cyprus.
Insights
Saphenous vein graft aneurysms (SVGAs) are rare but serious complications. This case highlights a novel SVGA occurrence post-percutaneous intervention, successfully treated with a covered stent.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Vascular Medicine
Background:
- Saphenous vein graft aneurysms (SVGAs) are infrequent complications of coronary artery bypass grafting, associated with increased morbidity and mortality.
- Atherosclerosis is the primary cause, though infections and surgical factors also contribute.
- SVGAs often present incidentally as cardiac or mediastinal masses on radiography.
Observation:
- Symptomatic presentations include chest pain, dyspnea, and myocardial infarction.
- This report details a unique case of an SVGA developing after percutaneous intervention, a previously undescribed etiology.
- The patient's SVGA was successfully managed using a polytetrafluoroethylene (PTFE) covered stent.
Findings:
- The case represents the first documented instance of an SVGA arising subsequent to percutaneous intervention.
- Successful treatment was achieved with a PTFE-covered stent, demonstrating its efficacy in this rare scenario.
Implications:
- This case expands the known spectrum of SVGA development and management.
- It underscores the importance of considering SVGA in patients with prior interventions presenting with relevant symptoms or imaging findings.
- The successful use of covered stents offers a viable treatment option for this specific complication.
Abstract:
Saphenous vein graft aneurysms (SVGAs) occur as a rare complication of coronary artery bypass graft but increases the risk of morbidity and mortality. Atherosclerosis is considered to be the most common cause of saphenous vein graft aneurysms. Other etiologies include infections, varicosities of vein grafts, and surgical technical issues. These aneurysms usually present as an incidental finding of a mediastinal or cardiac mass on chest radiograph. Symptomatic aneurysms may present with a wide variety of clinical manifestations such as chest pain/angina, shortness of breath, and myocardial infarction. Treatment options of SVG aneurysms include surgery, percutaneous intervention (including vascular plugs, covered stents, and embolization coils), and conservative management. Herein, we describe a case of a saphenous vein graft aneurysm that developed after percutaneous intervention, which has never been described, to our knowledge, in the previous literature. The aneurysm was treated with polytetrafluoroethylene covered stent implantation.
More Related Videos
09:04Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
06:55Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
Published on: October 26, 2016
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care